(115 days)
Not Found
No
The device is a standard medical glove and the summary contains no mention of AI or ML.
No
The device prevents contamination, it does not treat a condition or disease.
No
The device description clearly states it is for preventing contamination between patient and examiner, not for diagnosing any medical condition.
No
The device description and performance studies clearly indicate the device is a physical product (gloves) and there is no mention of any software component.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is clearly stated as "worn on the examiner's hands to prevent contamination between patient and examiner." This describes a barrier device used for infection control, not a device used to examine specimens derived from the human body for diagnostic purposes.
- Device Description: The description focuses on the physical properties and standards related to gloves (material, powder-free, color, standards like ASTM D6124, D5151, D6319). These are typical characteristics of medical gloves, not IVD devices.
- Lack of IVD Characteristics: There is no mention of analyzing samples (blood, urine, tissue, etc.), reagents, assays, or any other components typically associated with in vitro diagnostics.
- Performance Studies: The performance studies described focus on the physical integrity, biocompatibility (skin sensitization, irritation, cytotoxicity), and freedom from holes, which are relevant to the safety and effectiveness of a glove as a barrier. They do not involve diagnostic performance metrics like sensitivity, specificity, or accuracy in detecting a condition.
In summary, the device is a medical glove intended for barrier protection, not for performing diagnostic tests on samples outside the body.
N/A
Intended Use / Indications for Use
The Nitrile Patient Examination Gloves are disposable devices intended for medical purposes that are worn on the examiner's hands to prevent contamination between patient and examiner.
Product codes
LZA
Device Description
The proposed device is Powder Free Nitrile Patient Examination Gloves. The proposed device is blue. The design of proposed device is addressing the standards as ASTM D6124, ASTM D5151, and ASTM D6319. The proposed device is non-sterile.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
hands
Indicated Patient Age Range
Not Found
Intended User / Care Setting
examiner / medical purposes
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical tests were conducted to verify that the proposed device met all design specifications and acceptance criteria. The test results demonstrated that the proposed device complies with the following standards:
ISO 10993-10:2010 Biological Evaluation Of Medical Devices - Part 10: Tests For Irritation And Skin Sensitization.
ISO 10993-5:2009 Biological Evaluation Of Medical Devices - Part 5: Tests For In Vitro Cytotoxicity
ASTM D6124-06 (Reapproved 2017), Standard Test Method for Residual Powder on Medical Gloves
ASTM D5151-19, Standard Test Method for Detection of Holes in Medical Gloves.
ASTM D6319-19,Standard Specification For Nitrile Patient Examination Gloves For Medical Application.
ASTM D7160-16,Standard Practice for Determination of Expiration Dating for Medical Gloves
For 9-inch gloves:
Skin Sensitization Test: All grades are 0. All animals were survived and no abnormal signs were observed during the study.
Skin Irritation Test: The primary irritation index is 0. The response of the proposed device was categorized as negligible under the test condition.
Cytotoxicity Test: Viab.% of 100% test article extract is 71.6%. It means the proposed device have no potential toxicity to L-929 in the MTT method.
Residual Powder Test: 0.08 mg /glove.
Freedom from Holes Test: no glove water leakage found (Sample number: 125 gloves, AQL: 2.5 (ISO 2859), Criterion
§ 880.6250 Non-powdered patient examination glove.
(a)
Identification. A non-powdered patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. A non-powdered patient examination glove does not incorporate powder for purposes other than manufacturing. The final finished glove includes only residual powder from manufacturing.(b)
Classification. Class I (general controls). The device, when it is a finger cot, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 880.9.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
October 14, 2021
Yingxiang Glove Products Co., Ltd. % Boyle Wang General Manager Shanghai Truthful Information Technology Co., Ltd. Room 608, No.738, Shangcheng Rd., Pudong Shanghai, Shanghai 200120 China
Re: K211914
Trade/Device Name: Nitrile Patient Examination Gloves Regulation Number: 21 CFR 880.6250 Regulation Name: Non-Powdered Patient Examination Glove Regulatory Class: Class I, reserved Product Code: LZA Dated: September 7, 2021 Received: September 13, 2021
Dear Boyle Wang:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
1
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Clarence W. Murray, III, PhD Assistant Director DHT4B: Division of Infection Control and Plastic Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K211914
Device Name Nitrile Patient Examination Gloves
Indications for Use (Describe)
The Nitrile Patient Examination Gloves are disposable devices intended for medical purposes that are worn on the examiner's hands to prevent contamination between patient and examiner.
Type of Use (Select one or both, as applicable) | |
---|---|
------------------------------------------------- | -- |
Prescription Use (Part 21 CFR 801 Subpart D)
X Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary K211914
This summary of 510(k) is being submitted in accordance with 21 CFR 807.92.
1.0 submitter's information
Name: Yingxiang Glove Products Co., Ltd. Address: No. 1, Zhendong Industrial Park, Huagiao Town, Wuxue City, Huanggang City, Hubei Province, 435400, China Phone Number: +86-15982348869 Contact: Liu Penq Date of Preparation: 2021.06.06
Designated Submission Correspondent
Mr. Boyle Wanq Shanghai Truthful Information Technology Co., Ltd. Tel: +86-21-50313932 Email: Info@truthful.com.cn
2.0 Device information
Trade name: Nitrile Patient Examination Gloves Common name: Patient Examination Gloves Classification name: Non-powdered patient examination glove Model(s): 9-inch (S, M, L, XL), 12-inch (S, M, L, XL)
3.0 Classification
Production code: LZA Regulation number: 21CFR880.6250 Classification: Class I Panel: General Hospital
4.0 Predicate device information
- Manufacturer: Ever Global (Vietnam) Enterprise Corp Device: Disposable Powder Free Nitrile Examination Glove, White/ Blue/ Black/ Pink Color
4
510(k) number: K171422
5.0 Indications for Use
The Nitrile Patient Examination Gloves are disposable devices intended for medical purposes that are worn on the examiner's hands to prevent contamination between patient and examiner.
6.0 Device description
The proposed device is Powder Free Nitrile Patient Examination Gloves. The proposed device is blue. The design of proposed device is addressing the standards as ASTM D6124,ASTM D5151, and ASTM D6319. The proposed device is non-sterile.
7.0 Technological Characteristics Comparison
Item | Proposed device | Predicated device | Comparison |
---|---|---|---|
510(k) number | K211914 | K171422 | |
Product Code | LZA | LZA | Same |
Regulation No. | 21 CFR 880.6250 | 21 CFR 880.6250 | Same |
Class | I | I | Same |
Indications for Use | The Nitrile Patient | ||
Examination Gloves is a | |||
disposable device intended | |||
for medical purposes that | |||
is worn on the examiner's | |||
hands to prevent | |||
contamination between | |||
patient and examiner. | The Disposable Powder Free | ||
Nitrile Examination Glove, | |||
White/ Blue/ Black/ Pink Color | |||
is a disposable device | |||
intended for medical | |||
purposes that is worn on the | |||
examiner's hands to prevent | |||
contamination between | |||
patient and examiner. | Same | ||
Powdered or Powered free | Powdered free | Powdered free | Same |
Design Feature | ambidextrous | ambidextrous | Same |
Labeling Information | Single-use indication, | ||
powder free, device color, | |||
device name, glove size | |||
and quantity, Nitrile Patient | |||
Examination Gloves, | |||
Non-Sterile | Single-use indication, powder | ||
free, device color, device | |||
name, glove size and | |||
quantity, Disposable Powder | |||
Free Nitrile Examination | |||
Glove, Non-Sterile | Same |
Table1-General Comparison
Table2 Device Dimensions Comparison
Predicate | Designation | Size | Tolerance | ||||
---|---|---|---|---|---|---|---|
Device(K171422) | XS | S | M | L | XL |
5
Length, mm | 230 | 230 | 230 | 230 | 230 | min | |
---|---|---|---|---|---|---|---|
Width, mm | 75 | 85 | 95 | 105 | 115 | $\pm 5$ | |
Thickness, mm: | |||||||
Finger | 0.05 | min | |||||
Palm | 0.05 | min | |||||
Proposed Device | Designation | Size | Tolerance | ||||
S | M | L | XL | ||||
9-inch | Length, mm | 220 | 230 | 230 | 230 | min | |
Width, mm | 80 | 95 | 110 | 120 | $\pm 10$ | ||
12-inch | Length, mm | 220 | 230 | 230 | 230 | min | |
Width, mm | 80 | 95 | 110 | 120 | $\pm 10$ | ||
Thickness, mm: | |||||||
9-inch | Finger | 0.05 | |||||
12-inch | Palm | 0.05 | |||||
Remark | Analysis 1 |
Table3 Performance Comparison
Item | Proposed device | Predicated device | Comparison | |||
---|---|---|---|---|---|---|
Colorant | blue | White/ Blue/ Black/ Pink | Analysis2 | |||
9-inch | Physical Properties | Before Aging | Tensile Strength | 14MPa, min | 14MPa, min | SAME |
Ultimate Elongation | 500%min | 500%min | SAME | |||
After Aging | Tensile Strength | 14MPa, min | 14MPa, min | SAME | ||
Ultimate Elongation | 400%min | 400%min | SAME | |||
Comply with ASTM D6319 | Comply with ASTM D6319 | SAME | ||||
Freedom from Holes | Be free from holes when tested in accordance with ASTMD5151 AQL=2.5 | Be free from holes when tested in accordance with ASTMD5151 AQL=2.5 | SAME | |||
Powder Content | 0.08 | Meet the requirements of ASTM D6124 | SIMILAR | |||
12-inch | Physical Properties | Before Aging | Tensile Strength | 14MPa, min | 14MPa, min | SAME |
Ultimate | 500%min | 500%min | SAME |
6
Elongation | |||||
---|---|---|---|---|---|
After | |||||
Aging | Tensile | ||||
Strength | 14MPa, min | 14MPa, min | SAME | ||
Ultimate | |||||
Elongation | 400%min | 400%min | SAME | ||
Comply with ASTM D6319 | Comply with ASTM D6319 | SAME | |||
Freedom from Holes | Be free from holes when tested in | ||||
accordance with | |||||
ASTMD5151 | |||||
AQL=2.5 | Be free from holes when | ||||
tested in accordance with | |||||
ASTMD5151 AQL=2.5 | SAME | ||||
Powder Content | 0.11 | Meet the requirements of | |||
ASTM D6124 | SIMILAR |
Analysis1: The proposed device has different sizes and tolerances to the predicate device.
Analysis2: The proposed device has different color to the predicate device.
Table4 Safety Comparison
Item | Proposed device | Predicated device | Comparison | |
---|---|---|---|---|
Material | Nitrile | Nitrile | SAME | |
Biocompatibility | Irritation | Under the conditions of the study, not an irritant | Comply with ISO10993-10 | SAME |
Sensitization | Under conditions of the study, not a sensitizer. | |||
Cytotoxicity | Under conditions of the study, did not show potential toxicity to L-929 cells. | Comply with ISO10993-5 | SIMILAR | |
Label and Labeling | Meet FDA's Requirement | Meet FDA's Requirement | SAME |
8.0 Summary of Non-clinical Testing
Non-clinical tests were conducted to verify that the proposed device met all design specifications and acceptance criteria. The test results demonstrated that the proposed device complies with the following standards:
ISO 10993-10:2010 Biological Evaluation Of Medical Devices - Part 10: Tests For Irritation And Skin Sensitization.
ISO 10993-5:2009 Biological Evaluation Of Medical Devices - Part 5: Tests For In Vitro Cytotoxicity
7
ASTM D6124-06 (Reapproved 2017), Standard Test Method for Residual Powder on Medical Gloves
ASTM D5151-19, Standard Test Method for Detection of Holes in Medical Gloves.
ASTM D6319-19,Standard Specification For Nitrile Patient Examination Gloves For Medical Application.
ASTM D7160-16,Standard Practice for Determination of Expiration Dating for Medical Gloves
9-inch | ||||
---|---|---|---|---|
No. | Name of the Test | |||
Methodology / | ||||
Standard | Purpose | Acceptance Criteria | Results | |
1 | ISO 10993-10:2010 | |||
Biological | ||||
Evaluation Of | ||||
Medical Devices - | ||||
Part 10: Tests For | ||||
Irritation And Skin | ||||
Sensitization. | This part of ISO 10993 | |||
assesses possible | ||||
contact hazards from | ||||
chemicals released | ||||
from medical devices, | ||||
which may produce | ||||
skin and mucosal | ||||
irritation, eye irritation | ||||
or skin sensitization. | Skin Sensitization Test: | |||
provided grades less than 1, | ||||
otherwise sensitization. | All grades are 0. | |||
All animals were survived and no abnormal signs | ||||
were observed during the study. | ||||
2 | Skin Irritation Test: | |||
If the primary irritation index | ||||
is 0-0,4, the response | ||||
category is Negligible. | ||||
0,5-1,9 means slight | ||||
2-4,9 means moderate | ||||
5-8 means severe | The primary irritation index is 0. | |||
The response of the proposed device was | ||||
categorized as negligible under the test condition | ||||
3 | ISO 10993-5:2009 | |||
Biological | ||||
Evaluation Of | ||||
Medical Devices - | ||||
Part 5: Tests For In | ||||
Vitro Cytotoxicity | This part of ISO | |||
10993 describes test | ||||
methods to assess | ||||
the in vitro cytotoxicity | ||||
of medical devices. | The viab.% of the 100% | |||
extract of the test article is | ||||
the final result, and if | ||||
viability is reduced to | ||||
500% | ||||
After Accelerated Aging | ||||
Tensile strength ≥14MPa | ||||
Ultimate Elongation > | ||||
400% | ||||
Powder-free Residue: | ||||
pl. Refer to No. 4 in table 5 | N.A. | |||
Dimensions: | ||||
S: width: 81-87 mm | ||||
Length 228-234 mm | ||||
M: width 94-96 mm | ||||
Length 242-254 mm | ||||
L: width 100-109 mm | ||||
Length 268-274 mm | ||||
XL: width 112-119 mm | ||||
Length 245-252 mm | ||||
Thickness: | ||||
Finger 0.11-0.13 mm | ||||
Palm 0.07-0.08 mm | ||||
Physical properties: | ||||
Before aging | ||||
Tensile strength 16.72-26.66 MPa | ||||
Ultimate Elongation 518.19% - 849.65% | ||||
After Accelerated Aging | ||||
Tensile strength 15.34-21.73 MPa | ||||
Ultimate Elongation 560.54% - 799.91% | ||||
Powder-free Residue: | ||||
pl. Refer to No. 5 in table 5 | ||||
12-Inch | ||||
No. | Name of the Test | |||
Methodology / | ||||
Standard | Purpose | Acceptance Criteria | Results | |
1 | ISO 10993-10:2010 | |||
Biological | ||||
Evaluation Of | ||||
Medical Devices - | ||||
Part 10: Tests For | ||||
Irritation And Skin | ||||
Sensitization. | This part of ISO 10993 | |||
assesses possible | ||||
contact hazards from | ||||
chemicals released | ||||
from medical devices, | ||||
which may produce | ||||
skin and mucosal | ||||
irritation, eye irritation | ||||
or skin sensitization. | Skin Sensitization Test: | |||
provided grades | ||||
less than 1, | ||||
otherwise sensitization. | All grades are 0. | |||
All animals were survived and no abnormal signs | ||||
were observed during the study. | ||||
2 | Skin Irritation Test: | |||
If the primary irritation index | ||||
is 0-0,4, the response | ||||
category is Negligible. | ||||
0,5-1,9 means slight | ||||
2-4,9 means moderate | ||||
5-8 means severe | The primary irritation index is 0. | |||
The response of the | ||||
proposed device was | ||||
categorized as negligible under the test condition | ||||
3 | ISO 10993-5:2009 | |||
Biological | ||||
Evaluation Of | ||||
Medical Devices - | ||||
Part 5: Tests For In | ||||
Vitro Cytotoxicity | This part of ISO | |||
10993 describes test | ||||
methods to assess | ||||
the in vitro cytotoxicity | ||||
of medical devices. | The viab.% of the 100% | |||
extract of the test article is | ||||
the final result, and if | ||||
viability is reduced to |